New York University School of Medicine

Oncology & Cancer

Combination immune therapy shows promise against Hodgkin lymphoma

The combination of two new drugs that harness the body's immune system is safe and effective, destroying most cancer cells in 64 percent of patients with recurrent Hodgkin lymphoma, according to the results of an early-phase ...

page 9 from 30